Professional Documents
Culture Documents
Yudith Setiati Ermaya - Hematemesis Melena in Children - Pegasus
Yudith Setiati Ermaya - Hematemesis Melena in Children - Pegasus
st
1 - 2 JUNE 2024
Y u d i t h S e t i a t i E r m a y a
UKK
Gastrohepatologi
INTRODUCTION
1 PEG SU
st
Gastrointestinal Bleeding
(GIB)
Ringan
Mengancam
jiwa
DIAGNOSIS APPROACH
And
PROPER HANDLING
PEDIATRIC GASTROHEPATOLOGY UPDATE SYMPOSIUM
“UPDATES ON PEDIATRIC GASTROHEPATOLOGY MANAGEMENT IN DAILY PRACTICE”
Epidemiologi
Indonesia: no population-based
studies, no official data
USA:
UGI 6-25%
LGI 1%
UGI:
World: 20% GIB was Developing countries: 95% of UGI etiology is portal
UGI hypertension
Developed countries: 66% UGI= peptic ulcer & esophageal
bleeding
G
1 PEG SU
st
• Divided into:
• Upper gastrointestinal bleeding (UGB)
• Lower gastrointestinal bleeding (LGB)
PEDIATRIC GASTROHEPATOLOGY UPDATE SYMPOSIUM •J. Boyle, Gastrointestinal bleeding in infants and children, Pediatrics in review , DOI:10.1542/pir.29-2-39
•Corpus ID: 343864
“UPDATES ON PEDIATRIC GASTROHEPATOLOGY MANAGEMENT IN DAILY PRACTICE”
1 PEG SU
st
PEDIATRIC GASTROHEPATOLOGY UPDATE SYMPOSIUM John T. Boyle, Pediatrics in Review. 2008; Vol.29 No.2: 39-52
“UPDATES ON PEDIATRIC GASTROHEPATOLOGY MANAGEMENT IN DAILY PRACTICE”
1 PEG SU
st
Mucosal
Esofagitis Erosion The area is very large
Upper GI Bleeding
• Varises esofagus
• Peptic Ulcer
• Gastritis
Lower GI Bleeding
• Diverticulum meckel
• Intususepsi
PEDIATRIC GASTROHEPATOLOGY UPDATE SYMPOSIUM Omar NasherChildren 2017, 4(11), 95; https://doi.org/10.3390/children4110095
“UPDATES ON PEDIATRIC GASTROHEPATOLOGY MANAGEMENT IN DAILY PRACTICE”
CLINICAL MANIFESTATION GASTROINTESTINAL BLEEDING
1 PEG SU
st
= Muntah darah
Bleeding from the
upper GIB→ color
depends on how
long it has been in
contact with
stomach acid
Hematemesis
Fresh blood comes Black stools,
out through the distinctive odor. Hb is
anus and is the most
Melena
converted by bacteria
common into hematin/other
manifestation of LGI hemochromes
Hematochezia
Imaging:
❖ Abdomen imaging
❖ Ultrasonography
❖ Air Enema
❖ Dopler ultrasonography
❖ Meckel’s Scan
❖ Labeled RBC
❖ Angiografi
❖ Enterography
Endoscopy
Colonoscopy
Esofagogastroduodenoscopy
Ulkus Peptikum
• Etiology:
• Due to damage to the protective mucous
membrane of the stomach
• Helicobacter pylori infection
• NSAID drugs
• Zollinger-Ellyson
• Crohn's disease
• Group:
• Primary → Helicobacter pylori
• Secondary → NSAIDs, Chron's,
Zollinger-Ellyson
Meckel scan
• High
• Insidensi incidence
tinggi in (80%
pada bayi infants (80% in
pada
children
anak usia aged <1 year)
<1 tahun)
• Clinical
• Gejala Symptoms:
Klinis: keluar darah danblood and
lendir
mucus
dari anus, discharge
nyeri perut, from the anus,
• Pem. Fisis:
abdominal pain, massa usus
teraba/tampak
• Phisycalexaminaion:
seperti sosis, cembung, tegang (tanda
peritonitis)
palpable/visible intestinal mass
like a sausage, convex, tense
(sign of peritonitis)
Ultrasound:
Longitudinal: sandwich-like appearance
Sagittal: Dougnut sign → concentric
alternating echogenic and hypoechogenic
bands
Abdomen Photo:
With a contrast enema, it is obtained
Image of convex-shaped filling defect
Hematemesis
Pipa nasogastrik
Algoritme Pendekatan Manajemen Pasien dengan Perdarahan Saluran Cerna Atas yang Signifikan
Penilaian airway, breathing, circulation: Nilai tanda syok
• Menjaga patensi jalan nafas, oksigen, support pernafasan dan • Penggantian volume cairan dengan kristaloid, pemberian transfusi
sirkulasi sesuai indikasi
• Pemasakan akses vascular IV 2 line • Perbaiki gangguan koagulopati : vitamin K, transfusi FFP/trombosit
• Pemeriksaan darah lengkap, cross match, apusan darah tepi • Pemasangan NGT : bilas lambung dan observasi perdarahan
• Monitor tanda vital dan saturasi oksigen • Terapi supresi asam lambung
Mulai terapi okreotide, konsul divisi Gastroenterologi Anak Terapi supresi asam-PPI dosis tinggi
Tanpa Gejala Lain Anamnesis Dengan Gejala Lain (Gagal Tumbuh, Nyeri
Episode Pertama Pemeriksaan Fisis Perut, Purpura)
Prevention of
recurrent
Active bleeding bleeding Oral inhibitor of
gastric acid
secretion
Oral Adhesive
Intravenous inhibitors Protection of
of gastric acid secretion Ulcerated
Mucosa
Intravenous vasoactive
agents ocreotide Oral Prevention
of variceal
Rebleeding
PEDIATRIC GASTROHEPATOLOGY UPDATE SYMPOSIUM
“UPDATES ON PEDIATRIC GASTROHEPATOLOGY MANAGEMENT IN DAILY PRACTICE”
1 PEG SU
st
Intravenous Inhibitor of
ACTIVE Gastric Acid Secretion H2 Blocker
iv continuous → 1mg/kgBW
BLEEDING • Ranitidin followed by 2-4mg/kgBW/day
PPI
• Pantoprazole Bolus 3-5mg/kgBB/day, every 8
hours
Intravenous Vasoactive
Agents
Somatostatin analog
• Octreotide <40kg → 0.5 – 1 mg/kgBB/day
(once daily)
>40kg→ 20-40mg/day
Antidiuretic hormone (max
• Vasopresin 40mg/day)
1mcg/kgbb IV (max 50mcg) followed
• Terlipresin by 1mcg/kgbb/hour up to 4
• Somatostatin mcg/kgbb/hour (max
250mcg/8hours)
Trafficking (-) reduced by 50%
PEDIATRIC GASTROHEPATOLOGY UPDATE SYMPOSIUM every 12 hours, 24 to 48 hours
“UPDATES ON PEDIATRIC GASTROHEPATOLOGY MANAGEMENT IN DAILY PRACTICE”
1 PEG SU
st
Prevention of
recurrent
Oral inhibitor of gastric acid secretion
Antagonis H2:
bleeding • Ranitidin
Proton
2–3 mg/kgBW
Antagonis H2: perpump inhibitor:
dose 2–3x/day
• Famotidin (maximum, 1–1.5
0.5 mg/kgBW mg/kgBW
300per
mg/d) per day, 1–2x/day
dose 2x/day
• Lansoprazol Proton pump
(maximum, 40inhibitor:
(maximum, 30 mg 2x/day)
mg/day)
1–1.5 mg/kgBW per day, 1–2 times a day
• Omeprazol
(maximum, 20 mg twice a day)
Oral Adhesive Protection of Ulcerated Mucosa
• Sucralfat Local adhesive paste: 40–80 mg/kgBW per day divided into
4 doses (maximum, 1,000 mg/dose divided into 4 doses)
https://kemkes.go.id/eng/pnpk-2023---tata-
laksana-perdarahan-saluran-cerna-
❖ Diagnostic modalities for visualizing the location of gastrointestinal bleeding have now
developed, both from endoscopic and radiological techniques.
❖ Management of gastrointestinal bleeding requires multidisciplinary care involving experts
in gastroenterology, pediatric gastroenterology, digestive surgery, pediatric surgery,
anesthesia, radiology and other related professions with the main goal being diagnostics,
management and therapy of the source of bleeding.
❖ In general, treatment of gastrointestinal bleeding includes hemodynamic stabilization, fluid
resuscitation, NGT placement, PPI administration, blood transfusion if indicated,
prokinetics, therapeutic endoscopy, therapeutic colonoscopy and surgery.
https://kemkes.go.id/eng/pnpk-2023---tata-laksana-perdarahan-saluran-cerna-
PEDIATRIC GASTROHEPATOLOGY UPDATE SYMPOSIUM
“UPDATES ON PEDIATRIC GASTROHEPATOLOGY MANAGEMENT IN DAILY PRACTICE”
1 PEG SU
st
TERIMA
KASIH
UKK
Gastrohepatologi